| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2005-09-3741 |
| P698 | PubMed publication ID | 16424393 |
| P50 | author | Hildegard Greinix | Q47158589 |
| P2093 | author name string | Gerhard Rogler | |
| Gerard Socié | |||
| Julia Brenmoehl | |||
| Hans Herfarth | |||
| Ernst Holler | |||
| Vanderson Rocha | |||
| Anne M Dickinson | |||
| Graham Jackson | |||
| Reinhard Andreesen | |||
| Gottfried Fischer | |||
| Beate Steiner | |||
| Daniel Wolff | |||
| Joachim Hahn | |||
| Juergen Schoelmerich | |||
| Guenther Eissner | |||
| Jeorg Marienhagen | |||
| P433 | issue | 10 | |
| P921 | main subject | stem cell transplantation | Q65592366 |
| P304 | page(s) | 4189-4193 | |
| P577 | publication date | 2006-01-19 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination | |
| P478 | volume | 107 |
| Q63253927 | A constitutional variant in the transcription factor EP300 strongly influences the clinical outcome of patients submitted to allo-SCT |
| Q38855496 | A novel crosstalk between TLR4- and NOD2-mediated signaling in the regulation of intestinal inflammation |
| Q37188484 | Acute GvHD: pathogenesis and classification |
| Q37420496 | Acute graft-versus-host disease: from the bench to the bedside |
| Q54636018 | Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population. |
| Q51806981 | Association of IL6 and CCL2 gene polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation. |
| Q37815276 | Bacterial infections, alloimmunity, and transplantation tolerance |
| Q37349793 | Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease |
| Q33270568 | Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation |
| Q33642625 | Current and future approaches for control of graft-versus-host disease |
| Q28075204 | Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives |
| Q37875779 | Danger signals activating innate immunity in graft-versus-host disease |
| Q35224947 | Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation. |
| Q27314927 | Disease severity and mortality can be independently regulated in a mouse model of experimental graft versus host disease |
| Q86518787 | Donor TLR9 gene tagSNPs influence susceptibility to aGVHD and CMV reactivation in the allo-HSCT setting without polymorphisms in the TLR4 and NOD2 genes |
| Q27026616 | Evaluation of published single nucleotide polymorphisms associated with acute GVHD |
| Q80642990 | Evolution of Crohn's disease-associated Nod2 mutations |
| Q37973859 | GVHD prevention: an ounce is better than a pound |
| Q37369447 | GVHD: a continuing barrier to the safety of allogeneic transplantation |
| Q37734489 | Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes |
| Q57569138 | Genetic variants in the NOD2/CARD15 gene are associated with early mortality in sepsis patients |
| Q36996205 | Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes |
| Q37262519 | Genomic and proteomic analysis of allogeneic hematopoietic cell transplant outcome. Seeking greater understanding the pathogenesis of GVHD and mortality |
| Q83468020 | Graft-versus-host disease |
| Q28388806 | Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective |
| Q35016985 | HDAC inhibition and graft versus host disease |
| Q36988418 | Haematopoietic stem cell transplantation: can our genes predict clinical outcome? |
| Q38935186 | Hematopoietic stem cells and solid organ transplantation |
| Q28080914 | Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime? |
| Q35084400 | Innate immunity and transplantation tolerance: the potential role of TLRs/NLRs in GVHD |
| Q89496342 | Insights into the role of intestinal microbiota in hematopoietic stem-cell transplantation |
| Q33839876 | Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation |
| Q38460376 | Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease |
| Q38708017 | Lack of Both Nucleotide-Binding Oligomerization Domain-Containing Proteins 1 and 2 Primes T Cells for Activation-Induced Cell Death. |
| Q35237715 | Mapping MHC-resident transplantation determinants |
| Q41218016 | Microbial sensing by the intestinal epithelium in the pathogenesis of inflammatory bowel disease |
| Q33882051 | Molecular control of steady-state dendritic cell maturation and immune homeostasis |
| Q37369943 | NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies |
| Q38057238 | NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome |
| Q51819756 | NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation. |
| Q37377427 | NOD2 regulates hematopoietic cell function during graft-versus-host disease |
| Q35213018 | New advances in hematopoietic cell transplantation |
| Q37641063 | New perspectives on the biology of acute GVHD. |
| Q80813551 | No impact of NOD2/CARD15 on outcome after SCT |
| Q81770552 | No impact of NOD2/CARD15 on outcome after SCT: a reply |
| Q34077479 | Pathogenesis and management of graft-versus-host disease. |
| Q38132090 | Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses |
| Q36156559 | Pathophysiology of acute graft-versus-host disease: recent advances |
| Q34063337 | Polymorphisms in the base excision repair pathway and graft-versus-host disease |
| Q27001015 | Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
| Q39929451 | Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease. |
| Q34973978 | Recipient's genetic R702W NOD2 variant is associated with an increased risk of bacterial infections after orthotopic liver transplantation |
| Q57910691 | Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk models |
| Q36021322 | Simultaneous deletion of NOD1 and NOD2 inhibits in vitro alloresponses but does not prevent allograft rejection |
| Q43104684 | Targeting CD83 for the treatment of graft-versus-host disease |
| Q37026059 | Targeting deacetylases to improve outcomes after allogeneic bone marrow transplantation |
| Q47133267 | The different roles of innate immune receptors in inflammation and carcinogenesis between races |
| Q42252766 | The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation |
| Q39035437 | The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease. |
| Q35538922 | The intestinal microbiota: its role in health and disease |
| Q37214491 | The multiple facets of toll-like receptors in transplantation biology |
| Q41218452 | The role of bacteria and pattern recognition receptors in GVHD |
| Q26824436 | The role of pattern-recognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantation |
| Q83785575 | [Allogeneic hematopoietic stem cell transplantations] |
| Q83327005 | [Graft-versus-Host Disease (GvHD) - an update : Part 1: Pathophysiology, clinical features and classification of GvHD] |
Search more.